» Articles » PMID: 35801218

Vitamin D Levels in a Population from Argentina with Metabolic Disorders

Overview
Journal Porto Biomed J
Publisher Wolters Kluwer
Date 2022 Jul 8
PMID 35801218
Authors
Affiliations
Soon will be listed here.
Abstract

Methods: This observational study with a cross-sectional design included 151 patients with metabolic disorders (type 2 diabetes, hypothyroidism, type 2 diabetes with hypothyroidism, and excess weight). A fasting blood sample was collected and analyzed to determine the levels of 25-hydroxyvitamin D, calcium, glucose, hemoglobin A1c, thyroid-stimulating hormone, and free thyroxine. Anthropometric and blood pressure measurements were also performed.

Results: According to vitamin D values established by the Institute of Medicine, subjects with metabolic disorders group showed: 23% risk to bone health (9.42 ±3.O4ng/mL), 45% risk of insufficiency/deficiency (17.05 ±2.12ng/mL), and 32% had sufficient levels (26.34±6.74ng/mL), whereas healthy subjects group showed significantly higher values than metabolic diseases group (37.25± 7.72). In addition, vitamin D levels were inversely correlated with elevated body mass index (29.13±5.15kg/m), systolic blood pressure (126.50± 15.60 mm Hg), fast blood glucose (106.29±33.80 mg/dL), and hemoglobin A1c (6.40% ± 1.38%) values.

Conclusion: Subjects with metabolic disorders and with adequate nutritional intake of vitamin D-rich foods and frequent exposure to sunlight have low serum vitamin D concentrations compared to the general population and vitamin D status should be assessed in these patients.

Citing Articles

Chronic kidney disease prevalence in asymptomatic patients with risk factors-usefulness of serum cystatin C: a cross-sectional study.

Avila M, Luciardi M, Oldano A, Aleman M, Perez Aguilar R Porto Biomed J. 2023; 8(6):e233.

PMID: 38093795 PMC: 10715761. DOI: 10.1097/j.pbj.0000000000000233.


Vitamin D and the Thyroid: A Critical Review of the Current Evidence.

Babic Leko M, Juresko I, Rozic I, Pleic N, Gunjaca I, Zemunik T Int J Mol Sci. 2023; 24(4).

PMID: 36835005 PMC: 9964959. DOI: 10.3390/ijms24043586.

References
1.
Park J, Pichiah P, Cha Y . Vitamin D and Metabolic Diseases: Growing Roles of Vitamin D. J Obes Metab Syndr. 2019; 27(4):223-232. PMC: 6513299. DOI: 10.7570/jomes.2018.27.4.223. View

2.
Senyigit A . The association between 25-hydroxy vitamin D deficiency and diabetic complications in patients with type 2 diabetes mellitus. Diabetes Metab Syndr. 2019; 13(2):1381-1386. DOI: 10.1016/j.dsx.2019.01.043. View

3.
Palacios C, Gonzalez L . Is vitamin D deficiency a major global public health problem?. J Steroid Biochem Mol Biol. 2013; 144 Pt A:138-45. PMC: 4018438. DOI: 10.1016/j.jsbmb.2013.11.003. View

4.
Gaksch M, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T . Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS One. 2017; 12(2):e0170791. PMC: 5312926. DOI: 10.1371/journal.pone.0170791. View

5.
Jeong H, Park K, Lee M, Yang D, Kim S, Lee S . Vitamin D and Hypertension. Electrolyte Blood Press. 2017; 15(1):1-11. PMC: 5641496. DOI: 10.5049/EBP.2017.15.1.1. View